Service D'imagerie Guilloz, CHU, Nancy, 54000, France.
Eur Radiol. 2013 Sep;23(9):2602-11. doi: 10.1007/s00330-013-2867-1. Epub 2013 May 22.
To evaluate the relationship between multiple MR perfusion parameters and symptoms of patients with osteoid osteomas after percutaneous laser therapy.
MR perfusion studies of 20 patients diagnosed with an osteoid osteoma, treated with CT-guided percutaneous laser therapy, were retrospectively evaluated. Multiple perfusion parameters correlated with the treatment outcome and the presence of osteoid osteoma-related symptoms.
There were 16 successful treatments, 6 recurrences and a significant difference in the perfusion parameters of these groups (P < 0.0001). Patients with successful treatment demonstrated delayed progressive enhancement or no enhancement (mean time to peak = 182 s, mean delay to the arterial peak = 119.3 s). Patients with treatment failure demonstrated an early and steep enhancement (mean time to peak = 78 s and mean delay to the arterial peak = 24 s). Plasmatic volume and transfer constant values significantly changed after successful treatment (P < 0.008). MR perfusion has a sensitivity and a specificity higher than 90 % in the detection of recurrent osteoid osteomas.
The identification of an early and steep enhancement with short time to peak and a short delay between the arterial and nidus peaks on MR perfusion in the postoperative setting is highly indicative of an osteoid osteoma recurrence. Key points • Magnetic resonance perfusion is becoming widely used for several tumours. • MR perfusion measurements correlate well with osteoid osteoma-related symptoms. • MR perfusion has high diagnostic performance for osteoid osteoma recurrence. • MR perfusion can improve the diagnostic confidence of osteoid osteoma recurrence.
评估经皮激光治疗后骨样骨瘤患者多种磁共振灌注参数与症状的关系。
回顾性分析 20 例经 CT 引导经皮激光治疗的骨样骨瘤患者的磁共振灌注研究。将多种灌注参数与治疗效果及骨样骨瘤相关症状的存在相关联。
16 例治疗成功,6 例复发,这些组之间的灌注参数存在显著差异(P < 0.0001)。治疗成功的患者表现为延迟性渐进性增强或无增强(达峰时间的平均值 = 182 s,达动脉峰值的延迟时间平均值 = 119.3 s)。治疗失败的患者表现为早期和陡峭的增强(达峰时间的平均值 = 78 s,达动脉峰值的延迟时间平均值 = 24 s)。治疗成功后,血浆体积和转移常数值显著改变(P < 0.008)。磁共振灌注在检测复发性骨样骨瘤方面具有高于 90%的敏感性和特异性。
在术后磁共振灌注中,识别早期和陡峭的增强、达峰时间短以及动脉和病灶峰值之间的延迟时间短,高度提示骨样骨瘤复发。
关键点
·磁共振灌注在多种肿瘤的诊断中得到广泛应用。
·磁共振灌注测量与骨样骨瘤相关症状密切相关。
·磁共振灌注对骨样骨瘤复发具有较高的诊断性能。
·磁共振灌注可提高骨样骨瘤复发的诊断信心。